CLRB Historical Earnings image   This CLRB historical earnings page last updated 8/8/2022
CLRB Historical Revenue
PeriodHistorical Earnings DateGAAP
Q2 20228/5/2022NA
Q1 20225/10/2022NA
Q4 20213/21/2022NA
Q3 202111/8/2021NA
Q2 20218/9/2021NA
Q1 20215/10/2021NA
Q4 20203/2/2021NA
Q3 202011/9/2020NA
Q2 20208/10/2020NA
Q1 20205/7/2020NA
Q4 20193/9/2020NA
Q3 201911/12/2019NA
Q2 20198/12/2019NA
Q1 20195/6/2019NA
Q4 20182/26/2019NA
Q3 201811/13/2018NA
Q2 20188/10/2018NA
Q1 20185/11/2018NA
Q4 20173/21/2018NA
Q3 201711/9/2017NA
Q2 20178/14/2017NA
Q1 20175/11/2017NA
Q4 20163/15/2017NA
Q3 201611/10/2016NA
Q2 20168/11/2016NA
Q1 20165/12/2016NA
Q4 20153/10/2016NA
Q3 201511/12/2015NA
Q2 20158/12/2015NA
Q1 20155/21/2015NA
Q4 20143/24/2015NA
Q3 201411/11/2014NA
Q2 20148/20/2014NA
Q1 20145/14/2014NA
CLRB Historical Earnings EPS
PeriodHistorical Earnings DateGAAP
Q2 20228/5/2022-1.220
Q1 20225/10/2022-1.000
Q4 20213/21/2022-0.900
Q3 202111/8/2021-1.000
Q2 20218/9/2021-1.100
Q1 20215/10/2021-1.300
Q4 20203/2/2021-0.600
Q3 202011/9/2020-1.500
Q2 20208/10/2020-2.600
Q1 20205/7/2020-4.200
Q4 20193/9/2020-3.300
Q3 201911/12/2019-4.200
Q2 20198/12/2019-4.600
Q1 20195/6/2019-7.600
Q4 20182/26/20190.600
Q3 201811/13/2018-16.500
Q2 20188/10/2018-16.900
Q1 20185/11/2018-21.000
Q4 20173/21/2018-34.000
Q3 201711/9/2017-16.000
Q2 20178/14/2017-23.000
Q1 20175/11/2017-24.000
Q4 20163/15/2017-34.000
Q3 201611/10/2016-43.000
Q2 20168/11/2016-49.000
Q1 20165/12/201691.000
Q4 20153/10/2016-618.000
Q3 201511/12/2015-250.000
Q2 20158/12/2015-300.000
Q1 20155/21/2015-300.000
Q4 20143/24/2015-560.000
Q3 201411/11/2014-100.000
Q2 20148/20/2014-730.000
Q1 20145/14/2014-1000.000
Quotes delayed 20 minutes

Email EnvelopeFree CLRB Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Cellectar Biosciences (CLRB) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

CLSD Historical Earnings
CLSN Historical Earnings
CLVS Historical Earnings
CLXT Historical Earnings
CMAX Historical Earnings
CMD Historical Earnings
CMPI Historical Earnings
CMPX Historical Earnings
CMRX Historical Earnings
CNC Historical Earnings
What was the record high CLRB historical earnings result?
In terms of earnings or revenue, what is the best CLRB historical earnings result that Cellectar Biosciences has ever posted, and when?

✔️Accepted answer: Within our data set, the highest CLRB historical earnings result was set in Q1 2016, when Cellectar Biosciences posted results of 91.000/share. The most successful revenue quarter within our data set was Q2 2022 when Cellectar Biosciences reported revenue of NA.

What was the lowest Cellectar Biosciences historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest CLRB has reported, and when?

✔️Accepted answer: Within our data set, the lowest CLRB historical earnings result was set in Q1 2014, when Cellectar Biosciences posted results of -1000.000/share. The smallest revenue quarter within our data set was Q2 2022 when Cellectar Biosciences reported revenue of NA.

On this page we presented the CLRB historical earnings date information for Cellectar Biosciences. Reviewing that CLRB Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q1 2016, when CLRB posted gaap of 91.000/share. Meanwhile the lowest CLRB historical earnings result was in Q1 2014, when CLRB posted gaap of -1000.000/share. Moving to Cellectar Biosciencess historical revenue numbers, the largest revenue quarter in our data set was seen in Q2 2022 when CLRB reported NA in revenue, while the smallest revenue quarter was Q2 2022 when CLRB reported NA in revenue.

For self directed investors doing their due diligence on CLRB or any other given stock, their research can benefit from looking into all of the Cellectar Biosciences historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into Cellectar Biosciences historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for CLRB. Thanks for visiting, and the next time you need to research CLRB historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: Top Ten Hedge Funds Holding OBOR, ARA YTD Return, CFOK Insider Buying.

 

CLRB Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.